Global Hospital-Acquired Infection Diagnostics Market

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Hospital-Acquired Infection Diagnostics Market, by Product
1.4.2 Global Hospital-Acquired Infection Diagnostics Market, by Infection Type
1.4.3 Global Hospital-Acquired Infection Diagnostics Market, by Application
1.4.4 Global Hospital-Acquired Infection Diagnostics Market, by Test Type
1.4.5 Global Hospital-Acquired Infection Diagnostics Market, by End User
1.4.6 Global Hospital-Acquired Infection Diagnostics Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. Global Hospital-Acquired Infection Diagnostics Market by Product
4.1 Global Reagents & Consumables Market by Region
4.2 Global Instrument Market by Region

Chapter 5. Global Hospital-Acquired Infection Diagnostics Market by Infection Type
5.1 Global Urinary Tract Infections (UTI) Market by Region
5.2 Global Hospital Acquired Pneumonia Market by Region
5.3 Global Bloodstream Infections Market by Region
5.4 Global Surgical Site Infections Market by Region
5.5 Global Gastrointestinal Infections Market by Region
5.6 Global Others Market by Region

Chapter 6. Global Hospital-Acquired Infection Diagnostics Market by Application
6.1 Global Drug-Resistance Testing Market by Region
6.2 Global Disease Testing Market by Region

Chapter 7. Global Hospital-Acquired Infection Diagnostics Market by Test Type
7.1 Global Molecular Diagnostics Market by Region
7.2 Global Immunoassay Market by Region
7.3 Global Urinalysis Market by Region

Chapter 8. Global Hospital-Acquired Infection Diagnostics Market by End User
8.1 Global Hospital Market by Region
8.2 Global Standalone Laboratories Market by Region
8.3 Global Others Market by Region

Chapter 9. Global Hospital-Acquired Infection Diagnostics Market by Region
9.1 North America Hospital-Acquired Infection Diagnostics Market
9.1.1 North America Hospital-Acquired Infection Diagnostics Market by Product
9.1.1.1 North America Reagents & Consumables Market by Country
9.1.1.2 North America Instrument Market by Country
9.1.2 North America Hospital-Acquired Infection Diagnostics Market by Infection Type
9.1.2.1 North America Urinary Tract Infections (UTI) Market by Country
9.1.2.2 North America Hospital Acquired Pneumonia Market by Country
9.1.2.3 North America Bloodstream Infections Market by Country
9.1.2.4 North America Surgical Site Infections Market by Country
9.1.2.5 North America Gastrointestinal Infections Market by Country
9.1.2.6 North America Others Market by Country
9.1.3 North America Hospital-Acquired Infection Diagnostics Market by Application
9.1.3.1 North America Drug-Resistance Testing Market by Country
9.1.3.2 North America Disease Testing Market by Country
9.1.4 North America Hospital-Acquired Infection Diagnostics Market by Test Type
9.1.4.1 North America Molecular Diagnostics Market by Country
9.1.4.2 North America Immunoassay Market by Country
9.1.4.3 North America Urinalysis Market by Country
9.1.5 North America Hospital-Acquired Infection Diagnostics Market by End User
9.1.5.1 North America Hospital Market by Country
9.1.5.2 North America Standalone Laboratories Market by Country
9.1.5.3 North America Others Market by Country
9.1.6 North America Hospital-Acquired Infection Diagnostics Market by Country
9.1.6.1 US Hospital-Acquired Infection Diagnostics Market
9.1.6.1.1 US Hospital-Acquired Infection Diagnostics Market by Product
9.1.6.1.2 US Hospital-Acquired Infection Diagnostics Market by Infection Type
9.1.6.1.3 US Hospital-Acquired Infection Diagnostics Market by Application
9.1.6.1.4 US Hospital-Acquired Infection Diagnostics Market by Test Type
9.1.6.1.5 US Hospital-Acquired Infection Diagnostics Market by End User
9.1.6.2 Canada Hospital-Acquired Infection Diagnostics Market
9.1.6.2.1 Canada Hospital-Acquired Infection Diagnostics Market by Product
9.1.6.2.2 Canada Hospital-Acquired Infection Diagnostics Market by Infection Type
9.1.6.2.3 Canada Hospital-Acquired Infection Diagnostics Market by Application
9.1.6.2.4 Canada Hospital-Acquired Infection Diagnostics Market by Test Type
9.1.6.2.5 Canada Hospital-Acquired Infection Diagnostics Market by End User
9.1.6.3 Mexico Hospital-Acquired Infection Diagnostics Market
9.1.6.3.1 Mexico Hospital-Acquired Infection Diagnostics Market by Product
9.1.6.3.2 Mexico Hospital-Acquired Infection Diagnostics Market by Infection Type
9.1.6.3.3 Mexico Hospital-Acquired Infection Diagnostics Market by Application
9.1.6.3.4 Mexico Hospital-Acquired Infection Diagnostics Market by Test Type
9.1.6.3.5 Mexico Hospital-Acquired Infection Diagnostics Market by End User
9.1.6.4 Rest of North America Hospital-Acquired Infection Diagnostics Market
9.1.6.4.1 Rest of North America Hospital-Acquired Infection Diagnostics Market by Product
9.1.6.4.2 Rest of North America Hospital-Acquired Infection Diagnostics Market by Infection Type
9.1.6.4.3 Rest of North America Hospital-Acquired Infection Diagnostics Market by Application
9.1.6.4.4 Rest of North America Hospital-Acquired Infection Diagnostics Market by Test Type
9.1.6.4.5 Rest of North America Hospital-Acquired Infection Diagnostics Market by End User
9.2 Europe Hospital-Acquired Infection Diagnostics Market
9.2.1 Europe Hospital-Acquired Infection Diagnostics Market by Product
9.2.1.1 Europe Reagents & Consumables Market by Country
9.2.1.2 Europe Instrument Market by Country
9.2.2 Europe Hospital-Acquired Infection Diagnostics Market by Infection Type
9.2.2.1 Europe Urinary Tract Infections (UTI) Market by Country
9.2.2.2 Europe Hospital Acquired Pneumonia Market by Country
9.2.2.3 Europe Bloodstream Infections Market by Country
9.2.2.4 Europe Surgical Site Infections Market by Country
9.2.2.5 Europe Gastrointestinal Infections Market by Country
9.2.2.6 Europe Others Market by Country
9.2.3 Europe Hospital-Acquired Infection Diagnostics Market by Application
9.2.3.1 Europe Drug-Resistance Testing Market by Country
9.2.3.2 Europe Disease Testing Market by Country
9.2.4 Europe Hospital-Acquired Infection Diagnostics Market by Test Type
9.2.4.1 Europe Molecular Diagnostics Market by Country
9.2.4.2 Europe Immunoassay Market by Country
9.2.4.3 Europe Urinalysis Market by Country
9.2.5 Europe Hospital-Acquired Infection Diagnostics Market by End User
9.2.5.1 Europe Hospital Market by Country
9.2.5.2 Europe Standalone Laboratories Market by Country
9.2.5.3 Europe Others Market by Country
9.2.6 Europe Hospital-Acquired Infection Diagnostics Market by Country
9.2.6.1 Germany Hospital-Acquired Infection Diagnostics Market
9.2.6.1.1 Germany Hospital-Acquired Infection Diagnostics Market by Product
9.2.6.1.2 Germany Hospital-Acquired Infection Diagnostics Market by Infection Type
9.2.6.1.3 Germany Hospital-Acquired Infection Diagnostics Market by Application
9.2.6.1.4 Germany Hospital-Acquired Infection Diagnostics Market by Test Type
9.2.6.1.5 Germany Hospital-Acquired Infection Diagnostics Market by End User
9.2.6.2 UK Hospital-Acquired Infection Diagnostics Market
9.2.6.2.1 UK Hospital-Acquired Infection Diagnostics Market by Product
9.2.6.2.2 UK Hospital-Acquired Infection Diagnostics Market by Infection Type
9.2.6.2.3 UK Hospital-Acquired Infection Diagnostics Market by Application
9.2.6.2.4 UK Hospital-Acquired Infection Diagnostics Market by Test Type
9.2.6.2.5 UK Hospital-Acquired Infection Diagnostics Market by End User
9.2.6.3 France Hospital-Acquired Infection Diagnostics Market
9.2.6.3.1 France Hospital-Acquired Infection Diagnostics Market by Product
9.2.6.3.2 France Hospital-Acquired Infection Diagnostics Market by Infection Type
9.2.6.3.3 France Hospital-Acquired Infection Diagnostics Market by Application
9.2.6.3.4 France Hospital-Acquired Infection Diagnostics Market by Test Type
9.2.6.3.5 France Hospital-Acquired Infection Diagnostics Market by End User
9.2.6.4 Russia Hospital-Acquired Infection Diagnostics Market
9.2.6.4.1 Russia Hospital-Acquired Infection Diagnostics Market by Product
9.2.6.4.2 Russia Hospital-Acquired Infection Diagnostics Market by Infection Type
9.2.6.4.3 Russia Hospital-Acquired Infection Diagnostics Market by Application
9.2.6.4.4 Russia Hospital-Acquired Infection Diagnostics Market by Test Type
9.2.6.4.5 Russia Hospital-Acquired Infection Diagnostics Market by End User
9.2.6.5 Spain Hospital-Acquired Infection Diagnostics Market
9.2.6.5.1 Spain Hospital-Acquired Infection Diagnostics Market by Product
9.2.6.5.2 Spain Hospital-Acquired Infection Diagnostics Market by Infection Type
9.2.6.5.3 Spain Hospital-Acquired Infection Diagnostics Market by Application
9.2.6.5.4 Spain Hospital-Acquired Infection Diagnostics Market by Test Type
9.2.6.5.5 Spain Hospital-Acquired Infection Diagnostics Market by End User
9.2.6.6 Italy Hospital-Acquired Infection Diagnostics Market
9.2.6.6.1 Italy Hospital-Acquired Infection Diagnostics Market by Product
9.2.6.6.2 Italy Hospital-Acquired Infection Diagnostics Market by Infection Type
9.2.6.6.3 Italy Hospital-Acquired Infection Diagnostics Market by Application
9.2.6.6.4 Italy Hospital-Acquired Infection Diagnostics Market by Test Type
9.2.6.6.5 Italy Hospital-Acquired Infection Diagnostics Market by End User
9.2.6.7 Rest of Europe Hospital-Acquired Infection Diagnostics Market
9.2.6.7.1 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Product
9.2.6.7.2 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Infection Type
9.2.6.7.3 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Application
9.2.6.7.4 Rest of Europe Hospital-Acquired Infection Diagnostics Market by Test Type
9.2.6.7.5 Rest of Europe Hospital-Acquired Infection Diagnostics Market by End User
9.3 Asia Pacific Hospital-Acquired Infection Diagnostics Market
9.3.1 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Product
9.3.1.1 Asia Pacific Reagents & Consumables Market by Country
9.3.1.2 Asia Pacific Instrument Market by Country
9.3.2 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Infection Type
9.3.2.1 Asia Pacific Urinary Tract Infections (UTI) Market by Country
9.3.2.2 Asia Pacific Hospital Acquired Pneumonia Market by Country
9.3.2.3 Asia Pacific Bloodstream Infections Market by Country
9.3.2.4 Asia Pacific Surgical Site Infections Market by Country
9.3.2.5 Asia Pacific Gastrointestinal Infections Market by Country
9.3.2.6 Asia Pacific Others Market by Country
9.3.3 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Application
9.3.3.1 Asia Pacific Drug-Resistance Testing Market by Country
9.3.3.2 Asia Pacific Disease Testing Market by Country
9.3.4 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Test Type
9.3.4.1 Asia Pacific Molecular Diagnostics Market by Country
9.3.4.2 Asia Pacific Immunoassay Market by Country
9.3.4.3 Asia Pacific Urinalysis Market by Country
9.3.5 Asia Pacific Hospital-Acquired Infection Diagnostics Market by End User
9.3.5.1 Asia Pacific Hospital Market by Country
9.3.5.2 Asia Pacific Standalone Laboratories Market by Country
9.3.5.3 Asia Pacific Others Market by Country
9.3.6 Asia Pacific Hospital-Acquired Infection Diagnostics Market by Country
9.3.6.1 China Hospital-Acquired Infection Diagnostics Market
9.3.6.1.1 China Hospital-Acquired Infection Diagnostics Market by Product
9.3.6.1.2 China Hospital-Acquired Infection Diagnostics Market by Infection Type
9.3.6.1.3 China Hospital-Acquired Infection Diagnostics Market by Application
9.3.6.1.4 China Hospital-Acquired Infection Diagnostics Market by Test Type
9.3.6.1.5 China Hospital-Acquired Infection Diagnostics Market by End User
9.3.6.2 Japan Hospital-Acquired Infection Diagnostics Market
9.3.6.2.1 Japan Hospital-Acquired Infection Diagnostics Market by Product
9.3.6.2.2 Japan Hospital-Acquired Infection Diagnostics Market by Infection Type
9.3.6.2.3 Japan Hospital-Acquired Infection Diagnostics Market by Application
9.3.6.2.4 Japan Hospital-Acquired Infection Diagnostics Market by Test Type
9.3.6.2.5 Japan Hospital-Acquired Infection Diagnostics Market by End User
9.3.6.3 India Hospital-Acquired Infection Diagnostics Market
9.3.6.3.1 India Hospital-Acquired Infection Diagnostics Market by Product
9.3.6.3.2 India Hospital-Acquired Infection Diagnostics Market by Infection Type
9.3.6.3.3 India Hospital-Acquired Infection Diagnostics Market by Application
9.3.6.3.4 India Hospital-Acquired Infection Diagnostics Market by Test Type
9.3.6.3.5 India Hospital-Acquired Infection Diagnostics Market by End User
9.3.6.4 South Korea Hospital-Acquired Infection Diagnostics Market
9.3.6.4.1 South Korea Hospital-Acquired Infection Diagnostics Market by Product
9.3.6.4.2 South Korea Hospital-Acquired Infection Diagnostics Market by Infection Type
9.3.6.4.3 South Korea Hospital-Acquired Infection Diagnostics Market by Application
9.3.6.4.4 South Korea Hospital-Acquired Infection Diagnostics Market by Test Type
9.3.6.4.5 South Korea Hospital-Acquired Infection Diagnostics Market by End User
9.3.6.5 Singapore Hospital-Acquired Infection Diagnostics Market
9.3.6.5.1 Singapore Hospital-Acquired Infection Diagnostics Market by Product
9.3.6.5.2 Singapore Hospital-Acquired Infection Diagnostics Market by Infection Type
9.3.6.5.3 Singapore Hospital-Acquired Infection Diagnostics Market by Application
9.3.6.5.4 Singapore Hospital-Acquired Infection Diagnostics Market by Test Type
9.3.6.5.5 Singapore Hospital-Acquired Infection Diagnostics Market by End User
9.3.6.6 Malaysia Hospital-Acquired Infection Diagnostics Market
9.3.6.6.1 Malaysia Hospital-Acquired Infection Diagnostics Market by Product
9.3.6.6.2 Malaysia Hospital-Acquired Infection Diagnostics Market by Infection Type
9.3.6.6.3 Malaysia Hospital-Acquired Infection Diagnostics Market by Application
9.3.6.6.4 Malaysia Hospital-Acquired Infection Diagnostics Market by Test Type
9.3.6.6.5 Malaysia Hospital-Acquired Infection Diagnostics Market by End User
9.3.6.7 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market
9.3.6.7.1 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Product
9.3.6.7.2 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Infection Type
9.3.6.7.3 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Application
9.3.6.7.4 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by Test Type
9.3.6.7.5 Rest of Asia Pacific Hospital-Acquired Infection Diagnostics Market by End User
9.4 LAMEA Hospital-Acquired Infection Diagnostics Market
9.4.1 LAMEA Hospital-Acquired Infection Diagnostics Market by Product
9.4.1.1 LAMEA Reagents & Consumables Market by Country
9.4.1.2 LAMEA Instrument Market by Country
9.4.2 LAMEA Hospital-Acquired Infection Diagnostics Market by Infection Type
9.4.2.1 LAMEA Urinary Tract Infections (UTI) Market by Country
9.4.2.2 LAMEA Hospital Acquired Pneumonia Market by Country
9.4.2.3 LAMEA Bloodstream Infections Market by Country
9.4.2.4 LAMEA Surgical Site Infections Market by Country
9.4.2.5 LAMEA Gastrointestinal Infections Market by Country
9.4.2.6 LAMEA Others Market by Country
9.4.3 LAMEA Hospital-Acquired Infection Diagnostics Market by Application
9.4.3.1 LAMEA Drug-Resistance Testing Market by Country
9.4.3.2 LAMEA Disease Testing Market by Country
9.4.4 LAMEA Hospital-Acquired Infection Diagnostics Market by Test Type
9.4.4.1 LAMEA Molecular Diagnostics Market by Country
9.4.4.2 LAMEA Immunoassay Market by Country
9.4.4.3 LAMEA Urinalysis Market by Country
9.4.5 LAMEA Hospital-Acquired Infection Diagnostics Market by End User
9.4.5.1 LAMEA Hospital Market by Country
9.4.5.2 LAMEA Standalone Laboratories Market by Country
9.4.5.3 LAMEA Others Market by Country
9.4.6 LAMEA Hospital-Acquired Infection Diagnostics Market by Country
9.4.6.1 Brazil Hospital-Acquired Infection Diagnostics Market
9.4.6.1.1 Brazil Hospital-Acquired Infection Diagnostics Market by Product
9.4.6.1.2 Brazil Hospital-Acquired Infection Diagnostics Market by Infection Type
9.4.6.1.3 Brazil Hospital-Acquired Infection Diagnostics Market by Application
9.4.6.1.4 Brazil Hospital-Acquired Infection Diagnostics Market by Test Type
9.4.6.1.5 Brazil Hospital-Acquired Infection Diagnostics Market by End User
9.4.6.2 Argentina Hospital-Acquired Infection Diagnostics Market
9.4.6.2.1 Argentina Hospital-Acquired Infection Diagnostics Market by Product
9.4.6.2.2 Argentina Hospital-Acquired Infection Diagnostics Market by Infection Type
9.4.6.2.3 Argentina Hospital-Acquired Infection Diagnostics Market by Application
9.4.6.2.4 Argentina Hospital-Acquired Infection Diagnostics Market by Test Type
9.4.6.2.5 Argentina Hospital-Acquired Infection Diagnostics Market by End User
9.4.6.3 UAE Hospital-Acquired Infection Diagnostics Market
9.4.6.3.1 UAE Hospital-Acquired Infection Diagnostics Market by Product
9.4.6.3.2 UAE Hospital-Acquired Infection Diagnostics Market by Infection Type
9.4.6.3.3 UAE Hospital-Acquired Infection Diagnostics Market by Application
9.4.6.3.4 UAE Hospital-Acquired Infection Diagnostics Market by Test Type
9.4.6.3.5 UAE Hospital-Acquired Infection Diagnostics Market by End User
9.4.6.4 Saudi Arabia Hospital-Acquired Infection Diagnostics Market
9.4.6.4.1 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Product
9.4.6.4.2 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Infection Type
9.4.6.4.3 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Application
9.4.6.4.4 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Test Type
9.4.6.4.5 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by End User
9.4.6.5 South Africa Hospital-Acquired Infection Diagnostics Market
9.4.6.5.1 South Africa Hospital-Acquired Infection Diagnostics Market by Product
9.4.6.5.2 South Africa Hospital-Acquired Infection Diagnostics Market by Infection Type
9.4.6.5.3 South Africa Hospital-Acquired Infection Diagnostics Market by Application
9.4.6.5.4 South Africa Hospital-Acquired Infection Diagnostics Market by Test Type
9.4.6.5.5 South Africa Hospital-Acquired Infection Diagnostics Market by End User
9.4.6.6 Nigeria Hospital-Acquired Infection Diagnostics Market
9.4.6.6.1 Nigeria Hospital-Acquired Infection Diagnostics Market by Product
9.4.6.6.2 Nigeria Hospital-Acquired Infection Diagnostics Market by Infection Type
9.4.6.6.3 Nigeria Hospital-Acquired Infection Diagnostics Market by Application
9.4.6.6.4 Nigeria Hospital-Acquired Infection Diagnostics Market by Test Type
9.4.6.6.5 Nigeria Hospital-Acquired Infection Diagnostics Market by End User
9.4.6.7 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market
9.4.6.7.1 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Product
9.4.6.7.2 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Infection Type
9.4.6.7.3 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Application
9.4.6.7.4 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Test Type
9.4.6.7.5 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by End User

Chapter 10. Company Profiles
10.1 Bayer AG (Bayer Schering Pharma AG)
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent Strategies and Developments
10.1.5.1 Partnerships, Collaborations and Agreements
10.2 Danaher Corporation
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.3 Becton, Dickinson and Company
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.1 Recent Strategies and Developments
10.3.1.1 Partnerships, Collaborations and Agreements
10.3.1.2 Product Launches and Product Expansions
10.4 Hologic, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent Strategies and Developments
10.4.5.1 Partnerships, Collaborations and Agreements
10.4.5.2 Product Launches and Product Expansions
10.5 Ecolab, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 Recent Strategies and Developments
10.5.5.1 Product Launches and Product Expansions:
10.5.5.2 Geographical Expansions:
10.6 Pfizer, Inc.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Regional & Segmental Analysis
10.6.4 Research & Development Expense
10.6.5 Recent Strategies and Developments
10.6.5.1 Approvals and Trials:
10.6.5.2 Acquisitions and Mergers
10.7 Steris PLC
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expenses
10.8 Johnson & Johnson
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental &Regional Analysis
10.8.4 Research & Development Expenses
10.9 Abbott Laboratories
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expense
10.9.5 Recent Strategies and Developments
10.9.5.1 Approvals and Trials:
10.9.5.2 Product Launches and Product Expansions:
10.10. Merck Group
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental and Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent Strategies and Developments
10.10.5.1 Partnerships, Collaborations and Agreements


LIST OF TABLES
TABLE 1 GLOBAL HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET, 2018 - 2021, USD MILLION
TABLE 2 GLOBAL HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET, 2022 - 2028, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS- HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS- HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET
TABLE 5 ACQUISITION AND MERGERS- HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET
TABLE 6 APPROVALS AND TRIALS - HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET
TABLE 7 GLOBAL HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2018 - 2021, USD MILLION
TABLE 8 GLOBAL HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2022 - 2028, USD MILLION
TABLE 9 GLOBAL REAGENTS & CONSUMABLES MARKET BY REGION, 2018 - 2021, USD MILLION
TABLE 10 GLOBAL REAGENTS & CONSUMABLES MARKET BY REGION, 2022 - 2028, USD MILLION
TABLE 11 GLOBAL INSTRUMENT MARKET BY REGION, 2018 - 2021, USD MILLION
TABLE 12 GLOBAL INSTRUMENT MARKET BY REGION, 2022 - 2028, USD MILLION
TABLE 13 GLOBAL HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2018 - 2021, USD MILLION
TABLE 14 GLOBAL HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2022 - 2028, USD MILLION
TABLE 15 GLOBAL URINARY TRACT INFECTIONS (UTI) MARKET BY REGION, 2018 - 2021, USD MILLION
TABLE 16 GLOBAL URINARY TRACT INFECTIONS (UTI) MARKET BY REGION, 2022 - 2028, USD MILLION
TABLE 17 GLOBAL HOSPITAL ACQUIRED PNEUMONIA MARKET BY REGION, 2018 - 2021, USD MILLION
TABLE 18 GLOBAL HOSPITAL ACQUIRED PNEUMONIA MARKET BY REGION, 2022 - 2028, USD MILLION
TABLE 19 GLOBAL BLOODSTREAM INFECTIONS MARKET BY REGION, 2018 - 2021, USD MILLION
TABLE 20 GLOBAL BLOODSTREAM INFECTIONS MARKET BY REGION, 2022 - 2028, USD MILLION
TABLE 21 GLOBAL SURGICAL SITE INFECTIONS MARKET BY REGION, 2018 - 2021, USD MILLION
TABLE 22 GLOBAL SURGICAL SITE INFECTIONS MARKET BY REGION, 2022 - 2028, USD MILLION
TABLE 23 GLOBAL GASTROINTESTINAL INFECTIONS MARKET BY REGION, 2018 - 2021, USD MILLION
TABLE 24 GLOBAL GASTROINTESTINAL INFECTIONS MARKET BY REGION, 2022 - 2028, USD MILLION
TABLE 25 GLOBAL OTHERS MARKET BY REGION, 2018 - 2021, USD MILLION
TABLE 26 GLOBAL OTHERS MARKET BY REGION, 2022 - 2028, USD MILLION
TABLE 27 GLOBAL HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2018 - 2021, USD MILLION
TABLE 28 GLOBAL HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2022 - 2028, USD MILLION
TABLE 29 GLOBAL DRUG-RESISTANCE TESTING MARKET BY REGION, 2018 - 2021, USD MILLION
TABLE 30 GLOBAL DRUG-RESISTANCE TESTING MARKET BY REGION, 2022 - 2028, USD MILLION
TABLE 31 GLOBAL DISEASE TESTING MARKET BY REGION, 2018 - 2021, USD MILLION
TABLE 32 GLOBAL DISEASE TESTING MARKET BY REGION, 2022 - 2028, USD MILLION
TABLE 33 GLOBAL HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2018 - 2021, USD MILLION
TABLE 34 GLOBAL HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2022 - 2028, USD MILLION
TABLE 35 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, 2018 - 2021, USD MILLION
TABLE 36 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, 2022 - 2028, USD MILLION
TABLE 37 GLOBAL IMMUNOASSAY MARKET BY REGION, 2018 - 2021, USD MILLION
TABLE 38 GLOBAL IMMUNOASSAY MARKET BY REGION, 2022 - 2028, USD MILLION
TABLE 39 GLOBAL URINALYSIS MARKET BY REGION, 2018 - 2021, USD MILLION
TABLE 40 GLOBAL URINALYSIS MARKET BY REGION, 2022 - 2028, USD MILLION
TABLE 41 GLOBAL HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2018 - 2021, USD MILLION
TABLE 42 GLOBAL HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2022 - 2028, USD MILLION
TABLE 43 GLOBAL HOSPITAL MARKET BY REGION, 2018 - 2021, USD MILLION
TABLE 44 GLOBAL HOSPITAL MARKET BY REGION, 2022 - 2028, USD MILLION
TABLE 45 GLOBAL STANDALONE LABORATORIES MARKET BY REGION, 2018 - 2021, USD MILLION
TABLE 46 GLOBAL STANDALONE LABORATORIES MARKET BY REGION, 2022 - 2028, USD MILLION
TABLE 47 GLOBAL OTHERS MARKET BY REGION, 2018 - 2021, USD MILLION
TABLE 48 GLOBAL OTHERS MARKET BY REGION, 2022 - 2028, USD MILLION
TABLE 49 GLOBAL HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY REGION, 2018 - 2021, USD MILLION
TABLE 50 GLOBAL HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY REGION, 2022 - 2028, USD MILLION
TABLE 51 NORTH AMERICA HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET, 2018 - 2021, USD MILLION
TABLE 52 NORTH AMERICA HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET, 2022 - 2028, USD MILLION
TABLE 53 NORTH AMERICA HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2018 - 2021, USD MILLION
TABLE 54 NORTH AMERICA HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2022 - 2028, USD MILLION
TABLE 55 NORTH AMERICA REAGENTS & CONSUMABLES MARKET BY COUNTRY, 2018 - 2021, USD MILLION
TABLE 56 NORTH AMERICA REAGENTS & CONSUMABLES MARKET BY COUNTRY, 2022 - 2028, USD MILLION
TABLE 57 NORTH AMERICA INSTRUMENT MARKET BY COUNTRY, 2018 - 2021, USD MILLION
TABLE 58 NORTH AMERICA INSTRUMENT MARKET BY COUNTRY, 2022 - 2028, USD MILLION
TABLE 59 NORTH AMERICA HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2018 - 2021, USD MILLION
TABLE 60 NORTH AMERICA HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2022 - 2028, USD MILLION
TABLE 61 NORTH AMERICA URINARY TRACT INFECTIONS (UTI) MARKET BY COUNTRY, 2018 - 2021, USD MILLION
TABLE 62 NORTH AMERICA URINARY TRACT INFECTIONS (UTI) MARKET BY COUNTRY, 2022 - 2028, USD MILLION
TABLE 63 NORTH AMERICA HOSPITAL ACQUIRED PNEUMONIA MARKET BY COUNTRY, 2018 - 2021, USD MILLION
TABLE 64 NORTH AMERICA HOSPITAL ACQUIRED PNEUMONIA MARKET BY COUNTRY, 2022 - 2028, USD MILLION
TABLE 65 NORTH AMERICA BLOODSTREAM INFECTIONS MARKET BY COUNTRY, 2018 - 2021, USD MILLION
TABLE 66 NORTH AMERICA BLOODSTREAM INFECTIONS MARKET BY COUNTRY, 2022 - 2028, USD MILLION
TABLE 67 NORTH AMERICA SURGICAL SITE INFECTIONS MARKET BY COUNTRY, 2018 - 2021, USD MILLION
TABLE 68 NORTH AMERICA SURGICAL SITE INFECTIONS MARKET BY COUNTRY, 2022 - 2028, USD MILLION
TABLE 69 NORTH AMERICA GASTROINTESTINAL INFECTIONS MARKET BY COUNTRY, 2018 - 2021, USD MILLION
TABLE 70 NORTH AMERICA GASTROINTESTINAL INFECTIONS MARKET BY COUNTRY, 2022 - 2028, USD MILLION
TABLE 71 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2018 - 2021, USD MILLION
TABLE 72 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2022 - 2028, USD MILLION
TABLE 73 NORTH AMERICA HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2018 - 2021, USD MILLION
TABLE 74 NORTH AMERICA HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2022 - 2028, USD MILLION
TABLE 75 NORTH AMERICA DRUG-RESISTANCE TESTING MARKET BY COUNTRY, 2018 - 2021, USD MILLION
TABLE 76 NORTH AMERICA DRUG-RESISTANCE TESTING MARKET BY COUNTRY, 2022 - 2028, USD MILLION
TABLE 77 NORTH AMERICA DISEASE TESTING MARKET BY COUNTRY, 2018 - 2021, USD MILLION
TABLE 78 NORTH AMERICA DISEASE TESTING MARKET BY COUNTRY, 2022 - 2028, USD MILLION
TABLE 79 NORTH AMERICA HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2018 - 2021, USD MILLION
TABLE 80 NORTH AMERICA HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2022 - 2028, USD MILLION
TABLE 81 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2018 - 2021, USD MILLION
TABLE 82 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2022 - 2028, USD MILLION
TABLE 83 NORTH AMERICA IMMUNOASSAY MARKET BY COUNTRY, 2018 - 2021, USD MILLION
TABLE 84 NORTH AMERICA IMMUNOASSAY MARKET BY COUNTRY, 2022 - 2028, USD MILLION
TABLE 85 NORTH AMERICA URINALYSIS MARKET BY COUNTRY, 2018 - 2021, USD MILLION
TABLE 86 NORTH AMERICA URINALYSIS MARKET BY COUNTRY, 2022 - 2028, USD MILLION
TABLE 87 NORTH AMERICA HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2018 - 2021, USD MILLION
TABLE 88 NORTH AMERICA HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2022 - 2028, USD MILLION
TABLE 89 NORTH AMERICA HOSPITAL MARKET BY COUNTRY, 2018 - 2021, USD MILLION
TABLE 90 NORTH AMERICA HOSPITAL MARKET BY COUNTRY, 2022 - 2028, USD MILLION
TABLE 91 NORTH AMERICA STANDALONE LABORATORIES MARKET BY COUNTRY, 2018 - 2021, USD MILLION
TABLE 92 NORTH AMERICA STANDALONE LABORATORIES MARKET BY COUNTRY, 2022 - 2028, USD MILLION
TABLE 93 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2018 - 2021, USD MILLION
TABLE 94 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2022 - 2028, USD MILLION
TABLE 95 NORTH AMERICA HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY COUNTRY, 2018 - 2021, USD MILLION
TABLE 96 NORTH AMERICA HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY COUNTRY, 2022 - 2028, USD MILLION
TABLE 97 US HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET, 2018 - 2021, USD MILLION
TABLE 98 US HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET, 2022 - 2028, USD MILLION
TABLE 99 US HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2018 - 2021, USD MILLION
TABLE 100 US HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2022 - 2028, USD MILLION
TABLE 101 US HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2018 - 2021, USD MILLION
TABLE 102 US HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2022 - 2028, USD MILLION
TABLE 103 US HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2018 - 2021, USD MILLION
TABLE 104 US HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2022 - 2028, USD MILLION
TABLE 105 US HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2018 - 2021, USD MILLION

Please contact our Customer Support Center to get the complete Table of Contents